By Gwendolyn Wu | October 9, 2026 In a significant signal of renewed investor appetite for immunology-focused...
The landscape of preclinical drug development is undergoing a seismic shift. For decades, the standard procedure for...
In the rapidly shifting landscape of modern medicine, the divide between complex laboratory science and the bedside...
Introduction: A Strategic Partnership for Global Health The Director-General of the World Health Organization (WHO), Dr. Tedros...
A powerful new consensus has emerged among the Canadian public: the current, fragmented approach to breast cancer...
Oklahoma City, OK – In a discovery poised to redefine our understanding of aggressive cancers, new research...
London, UK – [Insert Date] – The global market for Alzheimer’s disease therapeutics is on the cusp...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
The landscape of modern oncology is undergoing a seismic shift. For decades, cancer treatment followed a relatively...
NEW YORK – In a powerful display of advocacy and scientific ambition, the Breast Cancer Research Foundation...
